Orthofix Medical Adds the Fitbone Limb Lengthening System
Orthofix Medical Inc. (NASDAQ: OFIX), a global medical device company focused on musculoskeletal healing products, extended its product line with a deal for the Fitbone limb lengthening system. Privately held Wittenstein SE, based in Igersheim, Germany, will get $18 million in cash and a manufacturing supply contract. The Fitbone intramedullary lengthening system is designed to lengthen femur and tibia bones. More than 3,500 cases in 15 countries have been performed with the technology. This transaction brings other potential applications of the technology, which are in preliminary development, including the Fitspine system for early onset scoliosis. Texas-based Orthofix, formerly known as... Read More »
Hot Healthcare Sectors for Investment, Growth & Consolidation in 2020
Every year, starting in November, the crystal balls come out and the prognostications begin. What will the new year bring? Who or what will make out better and who or what will not? We talked with Gary Herschman, a member of Epstein Becker Green’s Healthcare and Life Sciences practice, about the healthcare sectors he and his firm are watching in 2020. Here are their predictions for 2020. Health Care M&A: What do you see as the biggest themes in the healthcare industry this year? There are a lot of moving parts, from the discovery of new drugs to the shifting attention to post-acute care. Gary Herschman: We see three key “drivers” of health industry transformation that are already... Read More »
Anika Therapeutics, Inc. Announces Double Purchase
Anika Therapeutics, Inc. (NASDAQ: ANIK), a medical device company that develops therapeutic products for tissue protection, healing and repair, announced two acquisitions in mid-Januaryto bolster its device portfolio. For a modest sum of $35 million upfront and a potential $60 million in milestones, the company acquired Parcus Medical, LLC, which provides implant and instrumentation products used by surgeons to repair and reconstruct damaged ligaments and tendons due to sports injuries, trauma and disease. The deal will help expand Anika’s offerings into the ambulatory surgical center (ASC) market. Parcus reported $12.5 million in revenue in 2019. Anika also acquired Arthrosurface for $60... Read More »
2019’s Biggest Healthcare Deals, by Sector
2020 has just begun, which means it’s time to look back at the healthcare M&A landscape of 2019. Just three days into the new year, nearly 1,780 deals are already on the books for 2019. More deals will turn up as we search our many sources, but the number likely won’t top the record of 1,900-plus set in 2018. Thanks to the multi-billion-dollar deals announced in the Biotech and Pharmaceutical sectors, 2019 will set a new spending record. Preliminary data show $399.1 billion was spent on healthcare acquisitions last year, about 20% higher than in 2018. We expect that number to rise as we go through the year and the 10Ks and quarterly reports come out. It’s possible the... Read More »
Baxter International Adds Seprafilm
Baxter International Inc. (NYSE: BAX) is having a busy 2019. After acquiring Cheetah Medical in September for $190 million in cash, it announced last week it was taking Seprafilm off of Sanofi’s (NYSE: SNY) hands. Sanofi will get $350 million for the portfolio, which includes Seprafilm Adhesion Barrier and related assets. The product is indicated for use in patients undergoing abdominal or pelvic laparotomy as an adjunct intended to reduce adhesions between the abdominal wall and the underlying viscera. Seprafilm had global sales of $100 million in the past 12 months, including in markets such as the United States, Japan, China, South Korea and France. This acquisition builds... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
